Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
Open Access
- 1 March 2009
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 16 (1), 123-137
- https://doi.org/10.1677/erc-08-0124
Abstract
Urothelial carcinoma (UC) of the bladder is approximately three times more common in men than women. While the etiology for this gender difference in incidence remains unknown, a role for androgen receptor (AR) signaling has been suggested. The mechanisms by which AR activity is regulated in UC cells, however, are largely elusive. Here, we explore the significance of coregulators that are critical for the formation of a functional AR transcriptional complex, in UC cells. Using two AR-positive UC cell lines, TCC-SUP and UMUC3, we demonstrate the expression of the coactivators NCOA1, NCOA2, NCOA3, CREBBP, and EP300 in UC cells. small interfering RNA-mediated knockdown of the AR or any of these coactivators markedly impacted cell viability and abrogated androgen-dependent cell proliferation. Noteworthy, contrary to AR-positive prostate cancer cells, expression of these AR-associated coactivators was not androgen regulated in UC cells. To assess the clinical relevance of coactivator expression, we performed immunohistochemistry on paraffin-embedded sections from 55 patients with UC of the bladder. We found that while 24 out of 55 (44%) of tumors expressed the AR, each of the coactivators was expressed by 85–100% of the bladder cancers. Moreover, we noted a significant downregulation of NCOA1 expression in tumors versus adjacent, non-tumor bladder urothelium, with a mean of 68% (range 0–100) of tumor cells demonstrating NCOA1 staining versus a mean of 81% (range 0–90) of non-tumor cells (P=0.03). Taken together, our data suggest an important role for AR-associated coactivators in UC and point toward differences in the regulation of AR activity between bladder and prostate cancer cells.Keywords
This publication has 51 references indexed in Scilit:
- Defining Optimal Therapy for Muscle Invasive Bladder CancerJournal of Urology, 2007
- SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomasCancer Letters, 2007
- Molecular regulation of androgen action in prostate cancerJournal of Cellular Biochemistry, 2006
- Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell GrowthMolecular and Cellular Biology, 2003
- p300 in prostate cancer proliferation and progression.2003
- Androgen Dependent Regulation of bacillus Calmette-Guerin Induced Interleukin-6 Expression in Human Transitional Carcinoma Cell LinesJournal of Urology, 2003
- Review of the in Vivo Functions of the p160 Steroid Receptor Coactivator FamilyMolecular Endocrinology, 2003
- Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1The Journal of Steroid Biochemistry and Molecular Biology, 2002
- Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer CellsJournal of Biological Chemistry, 2002